Clinical trial
A Randomized Study of Repetitive Assessement of PRECISE-DAPT Score During Dual Antiplatelet Therapy: The RE-SCORE Trial
NCT03848572 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Study of Repetitive Assessement of PRECISE-DAPT Score During Dual Antiplatelet Therapy: The RE-SCORE Trial
- Lead sponsor
- University of Roma La Sapienza
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 1, 2017
- Completion date
- December 31, 2019
- Enrollment
- 500 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular diseases, interventional cardiology